Home > Healthcare > Medical Devices > Diagnostic Devices > Point of Care Ultrasound (POCUS) Market
Point of Care Ultrasound Market size was worth USD 3.5 billion in 2022 and is poised to witness significant growth at 6.9% CAGR up to 2032, driven by the growing number of pregnancies.
Rising birth rate throughout the world, particularly in underdeveloped nations, is increasing the adoption of portable ultrasound equipment. According to the UNICEF, India records nearly one fifth of the global annual child births, marking 25 million per year. When used extensively during pregnancy, POC ultrasonography precisely and rapidly reveals the fetus's health condition by detecting its heartbeat and any free fluid. Increasing adoption by most OB/GYN practitioners to provide quick solutions in cases where the mother or baby's life is in danger.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Point of Care Ultrasound Market Size in 2022: | USD 3.5 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 6.9% |
2032 Value Projection: | USD 6.8 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 245 |
Tables, Charts & Figures: | 385 |
Segments covered: | Type, Portability, Application, End-use, Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Irregular reimbursement regulations in point-of-care ultrasound imaging may stymie the market expansion to some extent. Several hospitals and clinics in this industry decline claims, particularly for pricey treatments for a variety of conditions. In many circumstances, the use of POCUS is deemed exploratory and is not a covered procedure. Furthermore, medical invoices containing plenty of information need many levels of verification and tedious documentation, and if erroneous, the claim may take longer to resolve.
The COVID-19 pandemic positively influenced the point of care ultrasound market revenue. During the outbreak, the use of point-of-care ultrasonography for patient treatment witnessed high demand to conduct clinical tests, since it is a proven technology for diagnosing various lung and cardiovascular disorders in real-time. As industry players increasingly established POCUS emergency solutions, this produced favorable environment for economic development. For instance, in March 2021, GE Healthcare, launched its second POCUS in a month, with a new AI-coupled device geared to assist frontline healthcare professionals dealing with COVID-19.
The ongoing R&D activities in the medical sector along with technical developments in ultrasound systems will augment the industry outlook. To cite an instance, recent research published in the African Journal of Emergency Medicine in 2023, recommends employing point-of-care ultrasonography to detect patients with low oxygen levels in resource-limited emergency settings. Furthermore, the rising demand for mobile POCUS devices or systems to improve patient outcomes and operational efficiency coupled with the continued efforts by prominent industry players to enhance and improve the performance of diagnostic ultrasound devices.
The diagnostics devices segment in the point of care ultrasound market is projected to generate over USD 4 billion by 2032. The growing frequency of chronic illnesses has increased the demand for ultrasonic imaging for the diagnosis of diseases owing to its cost-effectiveness compared to other medical imaging technologies. Additionally, several industry leaders are launching initiatives to offer ultrasound services. For instance, in September 2022, the Philips Foundation and RAD-AID International signed a multi-year cross-continental collaboration to provide ultrasound services to 50 million patients in low- and middle-income nations.
Trolley-based point of care ultrasound market is estimated to record 6.2% CAGR till 2032 driven by the increasing adoption of trolley-based devices in emergency care rooms. The rising advancements in technology have made way for more compact and portable trolley-based ultrasound systems to offer enhanced accessibility and usability in various healthcare settings. Furthermore, the growing awareness among healthcare professionals about the benefits of point-of-care ultrasound is promoting early diagnosis and intervention.
Point of care ultrasound market from the urology segment accounted for over USD 414 million in 2022 driven by the increasing product demand in urology clinics and emergency rooms due to the rising prevalence of urological disorders, including kidney stones, urinary tract infections, and prostate abnormalities. Urologists increasingly rely on ultrasound for non-invasive and real-time imaging of the urinary tract and reproductive organs. Technological advancements in the field of urology POC ultrasound has resulted in the availability of more efficient devices.
North America point of care ultrasound market held 33.6% share in 2022 and is estimated to be worth USD 2.3 billion by 2032. The high patient population suffering from chronic illnesses is responsible for this significant regional market share. According to the National Association of Chronic Disease Directors' 2022 report, approximately 60% of adult Americans suffer from at least one chronic condition. Furthermore, the strong presence of important industrial players together with the rising usage of new technologies.
The competitive landscape of the point of care ultrasound market includes leading companies such as:
Click here to Buy Section of this Report
By Type (USD Million & Units)
By Portability (USD Million)
By Application (USD Million)
By End-use (USD Million)
The above information is provided for the following regions and countries: